Business NewsPR NewsWire • Rational Vaccines Receives UK MHRA Innovation Passport for RVx201 for the Treatment of Genital Herpes Resulting From Herpes Simplex Type 2 (HSV-2) Virus

Rational Vaccines Receives UK MHRA Innovation Passport for RVx201 for the Treatment of Genital Herpes Resulting From Herpes Simplex Type 2 (HSV-2) Virus

Rational Vaccines Receives UK MHRA Innovation Passport for RVx201 for the Treatment of Genital Herpes Resulting From Herpes Simplex Type 2 (HSV-2) Virus

WOBURN, Mass. and OXFORD, U.K., July 22, 2021 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment of herpes to eradicate the disease, today announced that it has been awarded an Innovation Passport under a new process in the United Kingdom (UK) to bring...

View More : https://www.prnewswire.com:443/news-releases/rational-vaccines-receives-uk-mhra-innovation-passport-for-rvx201-for-the-t...
Releted News by prnewswire
CGTN: Peng Liyuan calls for women's education and poverty reduction
AIDA Cruises expands cruise program with new voyages with AIDAprima and AIDAblu
Rational Vaccines Receives UK MHRA Innovation Passport for RVx201 for the Treatment of Genital Herpes Resulting From Herpes Simplex Type 2 (HSV-2) Virus
130-я Кантонская ярмарка пройдет как в режиме онлайн, так и в традиционном формате
CINDE annonce : Intel Costa Rica porte son investissement à 600 millions de dollars et triple le nombre d'emplois annoncés
CINDE meldet: Intel Costa Rica erhöht die Investition auf 600 Millionen US-Dollar und verdreifacht die Zahl der angekündigten Arbeitsplätze